bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.20.649717

Activation of complement protein C3 depicts the dynamic tissue damage of the cochlea after noise trauma.

Abstract

Hearing loss is characterized by dysfunction and pathological changes of the cochlea, including the loss of sensory hair cells and connected synapses. Growing evidence has revealed that the immune system plays critical roles in shaping cochlear responses to tissue injury and the clearance of damaged cells under pathological conditions such as noise-induced hearing loss (NIHL). However, the underlying mechanisms that regulate this process remain unclear. As a crucial part of the innate immune system, the complement system is widely known to respond to tissue damage and help remove cellular debris. Such functions are yet to be fully explored in the auditory system, especially in the cochlea. Among various complement factors, the activation of complement protein C3 is an essential functional hub of the complement cascade, resulting in the phagocytosis of dead or dying cells. In this study, we sought to investigate whether C3 exists in the cochlea and what roles it might play upon noise injury. To test this, we studied C3 activation using immunohistochemistry in the cochleae of various mouse models that were noise exposed to an octave band noise (8-16 kHz) for two hours at 112 dB SPL. Mice were sacrificed at various post exposure times to examine cochlear pathology. We found damage dependent C3 activity in the organ of Corti in mice after noise exposure (NE), especially in damaged outer hair cell (OHC) area. Specifically, C3 opsonized damaged cellular structures include degenerating OHCs, OHC debris, ribbon synapses, and efferent synaptic boutons, and the temporal dynamics of the opsonization closely resemble the timing of cochlear tissue damages post exposure. Unexpectedly, C3-deficient mice exhibited similar ABR thresholds and OHC counts at baseline as wild type mice, as well as comparable ABR threshold shifts and OHC loss after NE. However, we observed significantly reduced MOC terminal bouton degeneration in C3-deficient mice upon 112 dB SPL noise injury, indicating that C3 does modulate tissue damage and clearance, at least at the MOC terminals. Our results suggest that complement C3 is dynamically activated in the cochlea upon noise injury, which may play significant roles in damage recognition and further immune recruitment during the development of NIHL.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Guo, Z., Seicol, B. J., Shenouda, M., Wang, A., Garrity, K., Lin, S., Xie, R.. 2025-04-24. Activation of complement protein C3 depicts the dynamic tissue damage of the cochlea after noise trauma.. https://doi.org/10.1101/2025.04.20.649717

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗